Developer docs
API playgroundTry for free, no card

Search company profiles

Clairyon

Full company profile

uuid02llq38

Namestring
Clairyon
Legal namestring
Clairyon
Websiteurl
clairyon.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Clairyon (formerly Healcisio Inc.) is a private healthcare AI company founded in 2022 and headquartered in La Jolla, California, that builds a multimodal AI-powered clinical intelligence platform for hospital systems and clinical teams. Its product stack centers on three proprietary deep learning models: COMPOSER for early sepsis prediction 4–48 hours before clinical suspicion (with claim of 75–85% false alarm reduction versus legacy systems), KIDMATCH for differentiating Kawasaki disease from MIS-C in pediatric patients (90%+ accuracy), and WUPERR for cross-hospital generalization trained on over 104,000 patient records across four healthcare systems. The platform is extended with GenAI-driven automated quality measure abstraction (e.g., CMS SEP-1), an AI agent for sepsis care compliance, and an outpatient personal health companion leveraging LLMs and consumer wearables for post-discharge surveillance.

The company serves enterprise healthcare provider customers—primarily academic hospital systems—through a direct enterprise field sales motion with clinical pilot validations and integration via HL7 FHIR. UC San Diego Health is the anchor reference customer (62+ monitored care units, 200,000+ patients impacted, 17% relative sepsis mortality reduction in a peer-reviewed study), with Rady Children's Hospital as the principal pediatric validation partner and SEQSTER as a recent data integration partner for real-time longitudinal records. It is HIPAA and SOC 2 Type II compliant and is pursuing FDA clearance for KIDMATCH.

Clairyon's business model is subscription-based SaaS deployed through hospital system contracts, though pricing is not publicly disclosed; the website relies on 'Request Demo' CTAs indicating quote-based enterprise agreements. The company is currently funded primarily by non-dilutive NIH grants (~ $2.37M disclosed across NIH STTR and RADx Tech awards) and a Nucleate San Diego prize, and operates with a small team of approximately 10–15 people spanning engineering, clinical, and program coordination roles.

Short descriptiontext

Clairyon is a La Jolla–based healthcare AI startup that builds a multimodal clinical intelligence platform—anchored by its COMPOSER sepsis prediction model and KIDMATCH pediatric diagnostic tool—deployed primarily at academic hospital systems via enterprise SaaS contracts.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, sepsis early prediction, hospital quality reporting, multimodal healthcare AI, patient deterioration monitoring
Industry2 codes
PRIMARYHLACAGAF
Sepsis, Deterioration & Rapid Response CDS
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Clinical Decision Support Software (Healthcare AI)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1AI-Powered Clinical Intelligence Platform
TypeSubscription Recurring
Description

SaaS-based clinical intelligence solutions deployed in hospital systems. Revenue likely generated through software licensing and subscription model based on care units monitored or patient volume.

clairyon.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Clairyon sells a multimodal AI-powered clinical intelligence platform for hospital systems, featuring real-time deep learning models that monitor patient data (vital signs, labs, medications, EHR notes) to predict adverse events such as sepsis 4-48 hours before clinical suspicion. Its products include COMPOSER for sepsis early warning, KIDMATCH for pediatric MIS-C vs. Kawasaki Disease differentiation, and WUPERR for multi-hospital generalization, with GenAI-powered automation of CMS quality measure abstraction (SEP-1).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 17% relative reduction in sepsis mortality (1.9 percentage point absolute decrease from 11.39% to 9.5%)
+6 more records
Product overview1 text field

Clairyon offers a unified multimodal AI-powered clinical intelligence platform with two core products: COMPOSER for real-time sepsis prediction and KIDMATCH for pediatric inflammatory condition differentiation. The platform is enhanced by WUPERR for multi-hospital generalization, GenAI-powered quality reporting automation, real-time clinical decision support, and outpatient monitoring via wearables. All solutions share a unified infrastructure for early adverse event detection, quality improvement, and patient outcome optimization.

Product and service4 records
1COMPOSER
CategoryClinical Decision Support Software
Description

Conformal Multidimension Prediction of Sepsis Risk (COMPOSER) is a deep learning model that continuously monitors over 150 patient variables (vital signs, lab results, medications, comorbidities, and EHR context) to predict sepsis 4-48 hours before clinical suspicion, with a 75-85% reduction in false alarms versus legacy systems. It is deployed for hospital emergency departments, ICUs, and wards.

2KIDMATCH
CategoryClinical Decision Support Software
Description

A deep learning algorithm that uses patient age, the five classic signs of clinical Kawasaki Disease, and 17 laboratory measurements to differentiate Multisystem Inflammatory Syndrome in Children (MIS-C) from Kawasaki Disease (KD) with 90%+ accuracy. It is intended for pediatric hospitals and pediatric emergency departments.

3WUPERR
CategoryClinical Decision Support Software
Description

Weight Uncertainty Propagation and Episodic Representation Replay (WUPERR) is a sepsis prediction model trained on EHR data of over 104,000 patients across four healthcare systems. It uses elastic weight consolidation and episodic representation replay to generalize across hospital settings without requiring patient-level data sharing.

4AI Agent for Sepsis Care Compliance
CategoryQuality Reporting and Compliance Automation Software
Description

An AI-driven Clinical Abstraction Agent that automates SEP-1 sepsis quality measure abstraction and delivers near-real-time compliance feedback to care teams, achieving 92% agreement with expert human reviewers and a 13 percentage-point improvement in SEP-1 compliance (from 70.1% to 82.9%). It is intended for hospital quality and sepsis program teams.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-11
Description

Strategic partnership to bring real-time patient data into sepsis care. SEQSTER's longitudinal health data platform integrates with Clairyon's predictive AI to power early warning and post-discharge surveillance capabilities. Combines SEQSTER's patient data orchestration with Clairyon's COMPOSER model for earlier sepsis detection and faster intervention.

Strategic tierMinorTypeOthers
Description

Listed as an industry partner on the company team page.

Strategic tierMinorTypeOthers
Description

Listed as an industry partner on the company team page.

4UC San Diego Health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Primary clinical partner and deployment site. UC San Diego Health is the anchor institution where COMPOSER was developed and first deployed. Multiple joint research studies published in peer-reviewed journals. Company co-founders and advisors affiliated with UCSD School of Medicine.

clairyon.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner for KIDMATCH algorithm validation. Data from 1,517 patients used to develop MIS-C vs Kawasaki disease differentiation algorithm. Algorithm externally validated on cohorts from multiple children's hospitals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1CLEW Medical
TypeDirect peer
Description

CLEW provides CLEWICU, a predictive analytics platform for ICU patients that uses AI to predict hemodynamic instability and deterioration hours in advance, directly competing with Clairyon's real-time clinical surveillance and deterioration prediction capabilities.

TypeBroad incumbent
Description

Wolters Kluwer's Sentri7 and POC Advisor early warning systems provide real-time sepsis surveillance and clinical decision support across thousands of hospitals, representing a broad incumbent competitor to Clairyon's enterprise hospital sepsis platform.

TypeBroad incumbent
Description

Epic embeds sepsis screening modules (e.g., Best Practice Advisories) directly within its dominant EHR platform used by most US academic medical centers — including UCSD — creating a major incumbent threat that Clairyon must displace or integrate alongside.

TypeDirect peer
Description

Inflammatix develops host-response based diagnostics and AI for acute infection and sepsis triage, targeting similar hospital decision support use cases around early sepsis identification and risk stratification that Clairyon addresses with COMPOSER.

5MedAware
TypeEmerging player
Description

MedAware applies AI-driven clinical decision support for medication safety and patient-specific risk identification in hospital workflows, representing an emerging adjacent player targeting the same hospital AI clinical decision support category as Clairyon.

TypeDirect peer
Description

PeraHealth's Rothman Index uses a proprietary algorithm to detect patient deterioration from EHR data in real time — a directly comparable patient surveillance and clinical deterioration early-warning approach to Clairyon's COMPOSER platform.

TypeDirect peer
Description

Etiometry's T3 Platform aggregates ICU data streams and applies AI to support clinical decision-making for critically ill patients, including pediatric populations — overlapping with both Clairyon's COMPOSER adult monitoring and KIDMATCH pediatric diagnostic applications.

TypeBroad incumbent
Description

GE Healthcare offers ICU patient monitoring (Edwards partnership), analytics, and hospital-wide clinical surveillance solutions that compete with Clairyon's real-time patient monitoring and deterioration prediction capabilities across health system buyers.

TypeBroad incumbent
Description

Philips provides IntelliVue patient monitoring and a portfolio of hospital clinical informatics and analytics solutions (including connected care/ICU offerings) that overlap with Clairyon's enterprise hospital surveillance and clinical intelligence positioning.

TypeDirect peer
Description

Prenosis develops the FDA-authorized Sepsis ImmunoScore, an AI-enabled diagnostic for early sepsis risk stratification that integrates EHR data with clinical biomarkers — directly competing with Clairyon's COMPOSER for sepsis early warning deployments in hospital systems.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clairyon

Clinical Decision Support Software (Healthcare AI)clairyon.com

Clairyon is a La Jolla–based healthcare AI startup that builds a multimodal clinical intelligence platform—anchored by its COMPOSER sepsis prediction model and KIDMATCH pediatric diagnostic tool—deployed primarily at academic hospital systems via enterprise SaaS contracts.

What Clairyon does

Clairyon (formerly Healcisio Inc.) is a private healthcare AI company founded in 2022 and headquartered in La Jolla, California, that builds a multimodal AI-powered clinical intelligence platform for hospital systems and clinical teams. Its product stack centers on three proprietary deep learning models: COMPOSER for early sepsis prediction 4–48 hours before clinical suspicion (with claim of 75–85% false alarm reduction versus legacy systems), KIDMATCH for differentiating Kawasaki disease from MIS-C in pediatric patients (90%+ accuracy), and WUPERR for cross-hospital generalization trained on over 104,000 patient records across four healthcare systems. The platform is extended with GenAI-driven automated quality measure abstraction (e.g., CMS SEP-1), an AI agent for sepsis care compliance, and an outpatient personal health companion leveraging LLMs and consumer wearables for post-discharge surveillance.

The company serves enterprise healthcare provider customers—primarily academic hospital systems—through a direct enterprise field sales motion with clinical pilot validations and integration via HL7 FHIR. UC San Diego Health is the anchor reference customer (62+ monitored care units, 200,000+ patients impacted, 17% relative sepsis mortality reduction in a peer-reviewed study), with Rady Children's Hospital as the principal pediatric validation partner and SEQSTER as a recent data integration partner for real-time longitudinal records. It is HIPAA and SOC 2 Type II compliant and is pursuing FDA clearance for KIDMATCH.

Clairyon's business model is subscription-based SaaS deployed through hospital system contracts, though pricing is not publicly disclosed; the website relies on 'Request Demo' CTAs indicating quote-based enterprise agreements. The company is currently funded primarily by non-dilutive NIH grants (~ $2.37M disclosed across NIH STTR and RADx Tech awards) and a Nucleate San Diego prize, and operates with a small team of approximately 10–15 people spanning engineering, clinical, and program coordination roles.

Clairyon firmographics

Firmographics
Name
Clairyon
Legal name
Clairyon
Website
https://clairyon.com
Company type
Private
Founded year
2022
Operating status
Operating
Short description
Clairyon is a La Jolla–based healthcare AI startup that builds a multimodal clinical intelligence platform—anchored by its COMPOSER sepsis prediction model and KIDMATCH pediatric diagnostic tool—deployed primarily at academic hospital systems via enterprise SaaS contracts.
Ownership category
akta.pro rank

Clairyon industry classification

Industry
Product category
Clinical Decision Support Software (Healthcare AI)
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLACAGAF
Sepsis, Deterioration & Rapid Response CDS
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Clinical decision support
  • Sepsis early prediction
  • Hospital quality reporting
  • Multimodal healthcare AI
  • Patient deterioration monitoring

Where Clairyon is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Clairyon business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. AI-Powered Clinical Intelligence Platform: SaaS-based clinical intelligence solutions deployed in hospital systems. Revenue likely generated through software licensing and subscription model based on care units monitored or patient volume.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Clairyon product offering

Product offering

Core offering

Clairyon sells a multimodal AI-powered clinical intelligence platform for hospital systems, featuring real-time deep learning models that monitor patient data (vital signs, labs, medications, EHR notes) to predict adverse events such as sepsis 4-48 hours before clinical suspicion. Its products include COMPOSER for sepsis early warning, KIDMATCH for pediatric MIS-C vs. Kawasaki Disease differentiation, and WUPERR for multi-hospital generalization, with GenAI-powered automation of CMS quality measure abstraction (SEP-1).

Product overview

Clairyon offers a unified multimodal AI-powered clinical intelligence platform with two core products: COMPOSER for real-time sepsis prediction and KIDMATCH for pediatric inflammatory condition differentiation. The platform is enhanced by WUPERR for multi-hospital generalization, GenAI-powered quality reporting automation, real-time clinical decision support, and outpatient monitoring via wearables. All solutions share a unified infrastructure for early adverse event detection, quality improvement, and patient outcome optimization.

Differentiator

Problem solved

Functional benefit

Products and services

  • COMPOSER Conformal Multidimension Prediction of Sepsis Risk (COMPOSER) is a deep learning model that continuously monitors over 150 patient variables (vital signs, lab results, medications, comorbidities, and EHR context) to predict sepsis 4-48 hours before clinical suspicion, with a 75-85% reduction in false alarms versus legacy systems. It is deployed for hospital emergency departments, ICUs, and wards.
  • KIDMATCH A deep learning algorithm that uses patient age, the five classic signs of clinical Kawasaki Disease, and 17 laboratory measurements to differentiate Multisystem Inflammatory Syndrome in Children (MIS-C) from Kawasaki Disease (KD) with 90%+ accuracy. It is intended for pediatric hospitals and pediatric emergency departments.
  • WUPERR Weight Uncertainty Propagation and Episodic Representation Replay (WUPERR) is a sepsis prediction model trained on EHR data of over 104,000 patients across four healthcare systems. It uses elastic weight consolidation and episodic representation replay to generalize across hospital settings without requiring patient-level data sharing.
  • AI Agent for Sepsis Care Compliance An AI-driven Clinical Abstraction Agent that automates SEP-1 sepsis quality measure abstraction and delivers near-real-time compliance feedback to care teams, achieving 92% agreement with expert human reviewers and a 13 percentage-point improvement in SEP-1 compliance (from 70.1% to 82.9%). It is intended for hospital quality and sepsis program teams.

Quantifiable outcome

  • 17% relative reduction in sepsis mortality (1.9 percentage point absolute decrease from 11.39% to 9.5%)
  • +6 more outcomes

Companies that use Clairyon

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Clairyon technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability10 records

Feature5 records

Clairyon partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • SEQSTERcoreTechnology or Integration · 11 June 2026Strategic partnership to bring real-time patient data into sepsis care. SEQSTER's longitudinal health data platform integrates with Clairyon's predictive AI to power early warning and post-discharge surveillance capabilities. Combines SEQSTER's patient data orchestration with Clairyon's COMPOSER model for earlier sepsis detection and faster intervention.
  • Xpertech SolutionsminorOthersListed as an industry partner on the company team page.
  • AstuteminorOthersListed as an industry partner on the company team page.
  • UC San Diego HealthcoreStrategic or Co-development PartnerPrimary clinical partner and deployment site. UC San Diego Health is the anchor institution where COMPOSER was developed and first deployed. Multiple joint research studies published in peer-reviewed journals. Company co-founders and advisors affiliated with UCSD School of Medicine.
  • Rady Children's HospitalcoreStrategic or Co-development PartnerClinical partner for KIDMATCH algorithm validation. Data from 1,517 patients used to develop MIS-C vs Kawasaki disease differentiation algorithm. Algorithm externally validated on cohorts from multiple children's hospitals.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Clairyon competitors and assessment

Company assessment

Direct peers

  • CLEW Medical: CLEW provides CLEWICU, a predictive analytics platform for ICU patients that uses AI to predict hemodynamic instability and deterioration hours in advance, directly competing with Clairyon's real-time clinical surveillance and deterioration prediction capabilities.
  • Inflammatix: Inflammatix develops host-response based diagnostics and AI for acute infection and sepsis triage, targeting similar hospital decision support use cases around early sepsis identification and risk stratification that Clairyon addresses with COMPOSER.
  • PeraHealth: PeraHealth's Rothman Index uses a proprietary algorithm to detect patient deterioration from EHR data in real time — a directly comparable patient surveillance and clinical deterioration early-warning approach to Clairyon's COMPOSER platform.
  • Etiometry: Etiometry's T3 Platform aggregates ICU data streams and applies AI to support clinical decision-making for critically ill patients, including pediatric populations — overlapping with both Clairyon's COMPOSER adult monitoring and KIDMATCH pediatric diagnostic applications.
  • Prenosis: Prenosis develops the FDA-authorized Sepsis ImmunoScore, an AI-enabled diagnostic for early sepsis risk stratification that integrates EHR data with clinical biomarkers — directly competing with Clairyon's COMPOSER for sepsis early warning deployments in hospital systems.

Broad incumbents

  • Wolters Kluwer: Wolters Kluwer's Sentri7 and POC Advisor early warning systems provide real-time sepsis surveillance and clinical decision support across thousands of hospitals, representing a broad incumbent competitor to Clairyon's enterprise hospital sepsis platform.
  • Epic Systems: Epic embeds sepsis screening modules (e.g., Best Practice Advisories) directly within its dominant EHR platform used by most US academic medical centers — including UCSD — creating a major incumbent threat that Clairyon must displace or integrate alongside.
  • GE Healthcare: GE Healthcare offers ICU patient monitoring (Edwards partnership), analytics, and hospital-wide clinical surveillance solutions that compete with Clairyon's real-time patient monitoring and deterioration prediction capabilities across health system buyers.
  • Philips: Philips provides IntelliVue patient monitoring and a portfolio of hospital clinical informatics and analytics solutions (including connected care/ICU offerings) that overlap with Clairyon's enterprise hospital surveillance and clinical intelligence positioning.

Emerging players

  • MedAware: MedAware applies AI-driven clinical decision support for medication safety and patient-specific risk identification in hospital workflows, representing an emerging adjacent player targeting the same hospital AI clinical decision support category as Clairyon.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Clairyon social profiles

Digital presence

Clairyon compliance and trust

Trust signal

Compliance2 records

Clairyon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clairyon leadership team

Management profile

Number of profiles

Profiles16 records

Clairyon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clairyon M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clairyon

What does Clairyon do?

Clairyon sells a multimodal AI-powered clinical intelligence platform for hospital systems, featuring real-time deep learning models that monitor patient data (vital signs, labs, medications, EHR notes) to predict adverse events such as sepsis 4-48 hours before clinical suspicion. Its products include COMPOSER for sepsis early warning, KIDMATCH for pediatric MIS-C vs. Kawasaki Disease differentiation, and WUPERR for multi-hospital generalization, with GenAI-powered automation of CMS quality measure abstraction (SEP-1).

Is Clairyon a public or private company?

Clairyon is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Clairyon founded?

Clairyon was founded in 2022.

Where is Clairyon based?

Clairyon is headquartered in San Diego, United States, in the North America region.

How does Clairyon make money?

One revenue line is on record: AI-Powered Clinical Intelligence Platform.

Who are Clairyon's main competitors?

Direct peers on record are CLEW Medical, Inflammatix, PeraHealth, Etiometry and Prenosis. Broad incumbents are Wolters Kluwer, Epic Systems, GE Healthcare and Philips. MedAware is listed as an emerging player.

Does Clairyon have an API?

No public API is recorded for Clairyon.

What industry is Clairyon in?

Clairyon's product category is Clinical Decision Support Software (Healthcare AI). Its primary akta.pro industry code is HLACAGAF, Sepsis, Deterioration & Rapid Response CDS, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 54151 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals